IPP Bureau

Sea Urchin spines inspire breakthrough sensor that detects water flow instantly
Sea Urchin spines inspire breakthrough sensor that detects water flow instantly

By IPP Bureau - March 06, 2026

Their findings, published in the journal Nature, reveal that the spines’ unique porous internal structure allows them to convert water movement into measurable electrical signals

FUJIFILM Biotechnologies launches purification technology for biologics
FUJIFILM Biotechnologies launches purification technology for biologics

By IPP Bureau - March 06, 2026

ShunzymeX leverages a proprietary protease to streamline purification

Bayer expands MRXperion power injector capabilities with FDA nod
Bayer expands MRXperion power injector capabilities with FDA nod

By IPP Bureau - March 06, 2026

The system also introduces Imaging Scanner Interface 2 (ISI2) capability, enabling direct communication between injector and scanner to improve exam coordination and operational efficiency

FDA okays JUXTAPID for kids with ultra-rare genetic cholesterol disorder
FDA okays JUXTAPID for kids with ultra-rare genetic cholesterol disorder

By IPP Bureau - March 06, 2026

Philips unveils next-gen CT system ‘Rembra’
Philips unveils next-gen CT system ‘Rembra’

By IPP Bureau - March 06, 2026

Designed for intense clinical environments, Rembra can handle up to 270 exams per day

Alembic enters US branded market with first sales of Pivya UTI treatment
Alembic enters US branded market with first sales of Pivya UTI treatment

By IPP Bureau - March 06, 2026

Pivya is Alembic’s first branded pharmaceutica product in the US and is being marketed through Alembic Therapeutics LLC

Granules India’s US packaging facility clears FDA inspection with zero observations
Granules India’s US packaging facility clears FDA inspection with zero observations

By IPP Bureau - March 06, 2026

The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices

Eugia Pharma launches Pomalidomide capsules in US market
Eugia Pharma launches Pomalidomide capsules in US market

By IPP Bureau - March 06, 2026

NATCO announces launch of Pomalidomide capsules in US
NATCO announces launch of Pomalidomide capsules in US

By IPP Bureau - March 05, 2026

It is also approved for?AIDS-related Kaposi sarcoma?after failure of highly active antiretroviral therapy, as well as for HIV-negative adult patients with Kaposi sarcoma

Ind-Swift earns EcoVadis silver medal for sustainability excellence
Ind-Swift earns EcoVadis silver medal for sustainability excellence

By IPP Bureau - March 05, 2026

The Silver Medal recognizes strong performance across sustainability, ethics, environment, labour & human rights, and responsible procurement

PK Healthcare granted accreditation under 6th edition by NABH
PK Healthcare granted accreditation under 6th edition by NABH

By IPP Bureau - March 05, 2026

The 6th Edition NABH framework places strong emphasis on patient safety protocols, robust clinical governance, risk management systems

Shyamakant Giri resigns as CEO of Gland Pharma
Shyamakant Giri resigns as CEO of Gland Pharma

By IPP Bureau - March 05, 2026

Giri stated he is stepping down to pursue new opportunities after careful consideration

Teva and Blackstone Life Sciences strike $400m deal to advance promising IBD therapy
Teva and Blackstone Life Sciences strike $400m deal to advance promising IBD therapy

By IPP Bureau - March 05, 2026

The funding will be spread over four years, with BXLS also eligible for regulatory and commercial milestones, plus royalties on worldwide sales

Moderna strikes $950 million global settlement with Arbutus & Genevant, clears legal hurdles for vaccine pipeline
Moderna strikes $950 million global settlement with Arbutus & Genevant, clears legal hurdles for vaccine pipeline

By IPP Bureau - March 05, 2026

Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law

KIMS Hospitals launches India’s first adaptive deep brain stimulation for Parkinson’s patients
KIMS Hospitals launches India’s first adaptive deep brain stimulation for Parkinson’s patients

By IPP Bureau - March 05, 2026

Built on the Percept Platform and enhanced with BrainSense technology, the system can adjust stimulation levels in real time, responding to brain signals without manual intervention

Latest Stories

Interviews

Packaging